Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.

Source:http://linkedlifedata.com/resource/pubmed/id/18274558

Download in:

View as

General Info

PMID
18274558